Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Baum

Showing results (211-220 of 470) with videos related to

Pageof 47
Sort By:
Journal of the American Academy of Dermatology|January 1, 1997
Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skinJ Reichrath, S M Müller, A Kerber, et al.
Der Anaesthesist|September 1, 1973
[Continuous monitoring of the arterial carbon dioxide tension by means of catheter electrodes and possibilities for clinical application (author's transl)]V Schulz, W Erdmann, H V Ulmer, et al.
Hybridoma|February 1, 1997
OVAREX MAb-B43.13:IFN-gamma could improve the ovarian tumor cell sensitivity to CA125-specific allogenic cytotoxic T cellsR Madiyalakan, R Yang, B C Schultes, et al.
The International Journal of Biological Markers|January 1, 1997
How to overcome the disturbing effects of human anti-mouse antibodies (HAMA) on in vitro assaysJ B Oltrogge, R P Baum, K N Lema, et al.
Pneumologie (Stuttgart, Germany)|January 18, 2012
[Expert dialogue: neuroendocrine tumours of the lungs and gastroenteropancreatic system]D Hörsch, Y Sayeg, R Bonnet, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 1998
Anti-idiotype induction therapy: anti-CA125 antibodies (Ab3) mediated tumor killing in patients treated with Ovarex mAb B43.13 (Ab1)B C Schultes, R P Baum, A Niesen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 10, 2021
Prostate-Specific Membrane Antigen Radioligand Therapy Using <sup>177</sup>Lu-PSMA I&T and <sup>177</sup>Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and DosimetryChristiane Schuchardt, Jingjing Zhang, Harshad R Kulkarni, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1995
Direct labeling of monoclonal antibodies with technetium-99m by photoactivationT R Sykes, T K Woo, R P Baum, et al.
Psycho-Oncology|February 26, 2009
Effects of treatment factors, comorbidities and health-related quality of life on self-efficacy for physical activity in cancer survivorsHeidi Y Perkins, George P Baum, Cindy L Carmack Taylor, et al.
Die Medizinische Welt|December 26, 1970
[Complications of tracheotomy and prolonged resuscitation in patients of an internal intensive care unit]G Schylla, H P Schuster, P Baum, et al.
Pageof 47

Showing results (211-220 of 470) with videos related to

Sort By:
Pageof 47
Journal of the American Academy of Dermatology|January 1, 1997
Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skinJ Reichrath, S M Müller, A Kerber, et al.
Der Anaesthesist|September 1, 1973
[Continuous monitoring of the arterial carbon dioxide tension by means of catheter electrodes and possibilities for clinical application (author's transl)]V Schulz, W Erdmann, H V Ulmer, et al.
Hybridoma|February 1, 1997
OVAREX MAb-B43.13:IFN-gamma could improve the ovarian tumor cell sensitivity to CA125-specific allogenic cytotoxic T cellsR Madiyalakan, R Yang, B C Schultes, et al.
The International Journal of Biological Markers|January 1, 1997
How to overcome the disturbing effects of human anti-mouse antibodies (HAMA) on in vitro assaysJ B Oltrogge, R P Baum, K N Lema, et al.
Pneumologie (Stuttgart, Germany)|January 18, 2012
[Expert dialogue: neuroendocrine tumours of the lungs and gastroenteropancreatic system]D Hörsch, Y Sayeg, R Bonnet, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 1998
Anti-idiotype induction therapy: anti-CA125 antibodies (Ab3) mediated tumor killing in patients treated with Ovarex mAb B43.13 (Ab1)B C Schultes, R P Baum, A Niesen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 10, 2021
Prostate-Specific Membrane Antigen Radioligand Therapy Using <sup>177</sup>Lu-PSMA I&T and <sup>177</sup>Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and DosimetryChristiane Schuchardt, Jingjing Zhang, Harshad R Kulkarni, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1995
Direct labeling of monoclonal antibodies with technetium-99m by photoactivationT R Sykes, T K Woo, R P Baum, et al.
Psycho-Oncology|February 26, 2009
Effects of treatment factors, comorbidities and health-related quality of life on self-efficacy for physical activity in cancer survivorsHeidi Y Perkins, George P Baum, Cindy L Carmack Taylor, et al.
Die Medizinische Welt|December 26, 1970
[Complications of tracheotomy and prolonged resuscitation in patients of an internal intensive care unit]G Schylla, H P Schuster, P Baum, et al.
Pageof 47